Fin Cascade

Prices as of 8 Oct 2026 close · Not investment advice

Best Agrolife Limited

NSE: BESTAGROPesticides & Agrochemicals

Share price

₹16.88

-4.04% close of 8 Oct 2026

Market cap ₹591 CrP/E 19.7

Price-based ratios (P/B, dividend yield, EV/EBITDA) are as of 7 Oct 2026, the close above is 8 Oct 2026.

Business score

How strong the business is, in one number. The parts behind it are in Pro.

45

out of 100 · worked out 8 Oct 2026

Your ratios

The numbers you want to see first. Tap Edit to change them.

Market cap

₹591 Cr

P/E ratio

19.7

P/B ratio

0.8

ROCE

5.2%

ROE

1.0%

Dividend yield

0.6%

Price & valuation chart

How the share price and its valuation have moved. Hover over the chart to see any day. Prices as of the last close.

Prices as of 8 Oct 2026 close52-week high ₹30.1152-week low ₹12.30

Answers

Simple answers to the questions investors ask most, from the company's own numbers.

How fast it has been growing

Our sales figures for this company step up at Mar 2021 and we hold nothing that says why, so we cannot honestly quote a growth rate across it.

Whether it grew faster than its sector

Our sales figures for this company step up at Mar 2021 and we hold nothing that says why, so there is no honest growth rate of its own to set against its sector.

Room to re-rate, or risk of de-rating

At 19.7× earnings against a market that pays 23.9× across 2199 companies we can price. Its own industry sits at 20.8×, across 5 companies. It is against its own five-year median of 23.5×, the 39th percentile of its own range.

Whether growth justifies the valuation

Its earnings are falling, so growth cannot justify the price.

Profit growthPrice per ₹1 profitPer 1% growth
Best Agrolife Limited — this one-65%/yr19.7×—
UPL Limited-21%/yr20.6×—
PI Industries Limited-1%/yr29.2×—
Sumitomo Chemical India Limited2%/yr35.9×₹17.9
Bayer Cropscience Limited1%/yr20.8×₹20.8
Sharda Cropchem Limited26%/yr10.4×₹0.40

Compared with companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.

How it compares with its peers

Against companies the exchange files under the same label (Pesticides & Agrochemicals), it ranks 19 of 23 on returns, 22 of 23 on growth, 20 of 23 on margin. That grouping comes from the exchange's filing category, so some of them may not be real rivals.

What makes it hard to beat — and is that still true?

No durable advantage shows in the numbers: it earns 5.2% on capital, ahead of 17% of companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.

Whether its growth pays for itself

Roughly — Over the last five years it made ₹121 crore of cash from the business and spent about as much on plant and equipment. But only about 15 of every 100 rupees of profit it reported over 8 years arrived as cash — the rest is tied up. Its cash comes back more slowly than it used to: it went from being waiting 52 days for its cash to waiting 103 days for its cash.

Profit reality check

Is the profit real cash? Simple checks on the accounts. Facts only, not advice.

6 of 9 checks clear · 67%

Latest result · Q1 FY27

What the last results showed. Whether management kept its word is in Pro.

Announced 30 Jul 2026 · Consolidated

Revenue

₹396 Cr

Revenue vs last year

+4.0%

Revenue vs last quarter

+154.0%

Net profit

₹41 Cr

Profit vs last year

+103.3%

Net margin

10.3%

EPS

₹1.15

Earnings call transcript · 31 Jul 2026

Checklist before you investPRO

Points for and against, in one list.

Key numbers & peers

The main numbers grouped by topic, and how the company compares with similar ones.

Price

Market cap
₹591 Cr
Prev close
₹16.88
52w High
₹34.4
52w Low
₹12.3
Enterprise value
₹942 Cr
Beta
0.8
Price CAGR 1y
-26.0%
Price CAGR 3y
-38.0%
Price CAGR 5y
-22.0%
Price CAGR 10y
27.0%

Ratios

Return on assets
0.5%
PEG ratio
-0.3
P/E ratio
19.7
P/B ratio
0.8
EV / EBITDA
10.4
Industry P/E
20.2
ROCE
5.2%
ROCE 5y average
21.8%
ROE
1.0%
Debt / Equity
0.6
Interest coverage
1.2
Dividend yield
0.6%
ROE 3y average
9.0%
ROE last year
1.0%

Annual P&L

Annual revenue
₹1,257 Cr
Annual profit
₹9 Cr
Operating margin
8.0%
Net profit margin
0.7%
EBITDA margin
8.0%
Sales growth 3y
-10.4%
Sales growth 5y
6.8%
Profit growth 3y
-65.0%
Profit growth 5y
-26.0%
EPS
₹0.3
Sales growth TTM
-24.0%
Profit growth TTM
-57.0%
Dividend payout
40.0%

Quarter P&L

Sales latest quarter
₹396 Cr
Profit latest quarter
₹41 Cr
YoY quarterly sales growth
3.9%
YoY quarterly profit growth
105.0%
OPM latest quarter
19.6%

Balance Sheet

Book Value
₹21.9
Face Value
₹1.0
Total debt
₹442 Cr
Total cash
₹98 Cr
Borrowings
₹442 Cr
Reserves / Equity
20.9

Cash Flow

Operating cash flow
₹97 Cr
Free cash flow
₹91 Cr
FCF yield
6.4%
Net cash flow
₹2 Cr

Shareholding

Promoter holding
50.4%
FII holding
5.6%
DII holding
2.1%
Public holding
41.9%

Peer comparison

CompanyPrice ₹P/EMkt cap ₹ CrDiv yield %Profit qtr ₹ CrProfit var %Sales qtr ₹ CrSales var %ROCE %
UPL495.0021.241,9131.21-73.092.610,181.010.510.1
P I Industries2,210.0031.033,5300.68244.2-39.01,702.3-10.415.0
Sumitomo Chemi.421.9536.821,0390.31216.59.31,054.10.623.5
Bayer Crop Sci.3,491.5021.415,6864.30321.615.41,835.0-4.229.1
Sharda Cropchem742.0510.76,7032.0288.0-38.31,073.89.030.3
Dhanuka Agritech891.8014.93,9850.2236.3-34.6461.9-12.623.8
Rallis India200.0317.03,8861.50125.030.01,022.06.814.1
Best Agrolife17.5921.16240.5740.7104.1396.23.95.2
Median316.2021.11,6530.1724.616.8383.7-2.315.4

Competes with: Bayer Cropscience Limited, Dhanuka Agritech Limited, NACL Industries Limited, PI Industries Limited, Rallis India Limited, Sharda Cropchem Limited, Sumitomo Chemical India Limited, UPL Limited

Quarterly results

Sales and profit for each of the last 13 quarters. Newest on the right. ₹ crore.

Consolidated · to 30 Jun 2026
Line itemJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales612811315135519747274274381517203156396
Expenses482667296202465600280270335439199183318
Material Cost791841334395158
Change in Inventories43-5713977-49-61
Purchases of Stock-in-Trade90143751874153
Employee Cost232524252525
Other Expenses354068363743
Operating Profit13014419-6755147-6446784-2778
OPM %21185.92-501120-2.121.5912151.85-1720
Other Income4-31131-014-2112
Exceptional items (within Other Income)000000
Interest12151915161616171413151215
Depreciation78611101011121010101010
Profit before tax115118-6-9232121-33-242652-20-4855
Tax %21193-223322-26-92226-36-2326
Net Profit9095-7-722195-24-222039-13-3741
EPS in Rs2.552.67-0.19-2.040.602.67-0.68-0.620.561.10-0.36-1.051.15
Diluted EPS in Rs-9.268.4216-0.36-1.051.15

Profit & loss

Yearly sales, costs and profit for 12 years, plus the last 12 months (TTM). ₹ crore.

Consolidated · to 31 Mar 2026
Line itemMar 2017Mar 2018Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales1271519051,2111,7461,8731,8141,2571,272
Expenses1261548541,0451,4321,6481,6141,1571,140
Material Cost794455
Change in Inventories193110
Purchases of Stock-in-Trade296311
Employee Cost10799
Other Expenses224181
Operating Profit1-251166314226200100132
OPM %0.50-1.40614181211810
Other Income147233552
Exceptional items (within Other Income)00
Interest125153962665355
Depreciation003122433434241
Profit before tax0051141253134961039
Tax %575100272624212710
Net Profit-003710519210670930
EPS in Rs-0.0401.122.955.412.991.970.250.84
Diluted EPS in Rs300.25
Dividend Payout %0798125471040

Compounded growth

Average yearly growth over different spans, as stored. A span can cross a demerger or an acquisition.

Compounded sales growth

10 years
—
5 years
7%
3 years
-10%
TTM
-24%

Compounded profit growth

10 years
—
5 years
-26%
3 years
-65%
TTM
-57%

Stock price CAGR

10 years
27%
5 years
-22%
3 years
-38%
1 year
-26%

Return on equity

10 years
—
5 years
18%
3 years
9%
Last year
1%

Balance sheet

What the company owns and what it owes, at the end of each year. ₹ crore.

Consolidated
Line itemMar 2017Mar 2018Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital88222424242435
Reserves4648108306504623734733
Borrowings01933270568637478442
Other Liabilities6335209384380729713470
Total Liabilities1171103729841,4752,0131,9491,681
Fixed Assets0019180203362374351
CWIP0045141511
Investments323000011
Other Assets851073498001,2581,6361,5731,328
Total Assets1171103729841,4752,0131,9501,681

Cash flows

Real money coming in and going out each year — from the business, from investments and from loans. ₹ crore.

Consolidated
Line itemMar 2017Mar 2018Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity-14-4113-60-1803622897
Cash from Investing Activity-34318-15-19-63-291
Cash from Financing Activity4810-1167248-1-199-96
Net Cash Flow0-010-849-29-02
Free Cash Flow-14-426-66-218-1020891

Ratios

How fast customers pay, how long stock sits, and how well capital earns — year by year.

Consolidated
Line itemMar 2017Mar 2018Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days858753777391113142
Inventory Days67199391864577564
Days Payable72124167521404277
Cash Conversion Cycle858748152297434286430
Working Capital Days601503352474364103
ROCE %0413416135

Shareholding pattern

Who owns the company — founders (promoters), foreign funds, Indian funds and the public. In %.

Consolidated · to 30 Jun 2026
Line itemSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters505050505050505050505050
FIIs9.868.868.778.738.035.115.805.755.755.635.535.56
DIIs2.632.532.532.532.672.742.742.742.112.112.112.13
Public373939393942414142424242
No. of Shareholders31,94037,57139,86141,57040,57337,66637,49436,63037,18138,18068,25466,662

Price trend

The price as a Renko brick chart: small moves drop out so the bigger path stands out.

Change over 1 year -25.4% (₹22.62 → ₹16.88)Brick size ₹0.84 (fixed)Bricks 66
₹15.00₹20.00₹25.00₹30.00₹16.88Dec '25Feb '26Apr '26Jun '26Aug '26
Price moved up one brickPrice moved down one brickLast close ₹16.88 on 8 Oct 2026

Every brick is the same size, about one typical day's move. A new brick needs a full brick's move; turning the other way needs two. Bricks show where the price went, not where it will go.

Open interestPRO

Where option traders are positioned on this stock.

Industry numbers

The numbers that matter most in this industry, from the company's own filings.

1 when an audit qualification is filed as repetitive

0.00flag

2026-03-31

the company's own unlisted debt securities in default at period end

0.00cr

2026-06-30

the company's own loans / revolving facilities in default at period end (standalone filing)

0.00cr

2026-06-30

guarantees / comfort given for promoter, promoter group, directors and KMP

0.00cr

2026-03-31

loans outstanding to promoter, promoter group, directors and KMP (governance filing)

0.00cr

2026-03-31

security given for the borrowing of promoter, promoter group, directors and KMP

0.00cr

2026-03-31

FY revenue / permanent employees + workers, same basis (calc)

1,99,83,921inr

2026-03-31

News

News and filings about Best Agrolife Limited. Open one to see why it matters.

No recent news for this company.

Supply chain

Who it buys from, sells to and competes with — as recorded in our map of company links.

Uses as raw material

  • Atrazine technical
  • Butachlor technical
  • Emamectin Benzoate technical
  • Glyphosate technical
  • Oxyfluorfen technical

Buys drug ingredients from

  • Nantong Jiangshan Agrochemical & Chemicals Limited
  • Qilu Synva Pharmaceutical Co. Ltd.
  • Shangyu Nutrichem Company Limited

Sells to

  • Syngenta · Pyroxasulfone 85% WG herbicide (Movondo)

About

What the company is, from our own records: where it sits, where it makes things, and what it is made of.

Sector
Chemicals
Industry
Pesticides & Agrochemicals
Classification
Chemicals › Pesticides & Agrochemicals
ISIN
INE052T01021

Plants

  • Best Agrolife Gajraula technical plant
  • Best Agrolife Jammu formulations plant

News impact

Big market events that reach Best Agrolife Limited, and how the effect spreads.

No recent market events reach this company.

Dividends, splits & big trades

Money paid out, share splits and buybacks, and big buys or sells by funds and insiders.

Dividends

22 Sep 2026unspecified₹0.1
16 Jan 2026split₹0
16 Jan 2026bonus₹0
23 Sep 2025unspecified₹3
23 Sep 2024unspecified₹3
20 Sep 2022unspecified₹2
20 Sep 2021unspecified₹2

Splits, bonuses & buybacks

  • daily-prices repair: 24 rows from NSE's archive (replace 19, delete 3, insert 2), 2023-05-17..2026-05-28 (docs/flat_day_repair.md)1× · 17 May 2023

Bulk & block deals

DateWhoBought / soldSharesPrice
31 Jul 2026SILVERLEAF CAPITAL SERVICES PRIVATE LIMITEDSELL17,92,955₹18.74
31 Jul 2026SILVERLEAF CAPITAL SERVICES PRIVATE LIMITEDBUY17,92,955₹18.71

Documents

Annual reports, results presentations and earnings calls, straight from the source.

Facts from company filings and exchange data. Not investment advice: nothing here tells you to buy or sell.